229 related articles for article (PubMed ID: 26505644)
1. Analysis of the ToxCast Chemical-Assay Space Using the Comparative Toxicogenomics Database.
Hu B; Gifford E; Wang H; Bailey W; Johnson T
Chem Res Toxicol; 2015 Nov; 28(11):2210-23. PubMed ID: 26505644
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Pfizer compounds in EPA's ToxCast chemicals-assay space.
Shah F; Greene N
Chem Res Toxicol; 2014 Jan; 27(1):86-98. PubMed ID: 24328225
[TBL] [Abstract][Full Text] [Related]
3. Using ToxCast to Explore Chemical Activities and Hazard Traits: A Case Study With Ortho-Phthalates.
Pham N; Iyer S; Hackett E; Lock BH; Sandy M; Zeise L; Solomon G; Marty M
Toxicol Sci; 2016 Jun; 151(2):286-301. PubMed ID: 26969370
[TBL] [Abstract][Full Text] [Related]
4. Comparative endpoint sensitivity of in vitro estrogen agonist assays.
Dreier DA; Connors KA; Brooks BW
Regul Toxicol Pharmacol; 2015 Jul; 72(2):185-93. PubMed ID: 25896097
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of ToxCast Test Results with In Vivo and Other In Vitro Endpoints for Neuro, Endocrine, and Developmental Toxicities: A Case Study Using Endosulfan and Methidathion.
Silva M; Pham N; Lewis C; Iyer S; Kwok E; Solomon G; Zeise L
Birth Defects Res B Dev Reprod Toxicol; 2015 Apr; 104(2):71-89. PubMed ID: 26017137
[TBL] [Abstract][Full Text] [Related]
6. Contribution of new technologies to characterization and prediction of adverse effects.
Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C
Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431
[TBL] [Abstract][Full Text] [Related]
7. A CTD-Pfizer collaboration: manual curation of 88,000 scientific articles text mined for drug-disease and drug-phenotype interactions.
Davis AP; Wiegers TC; Roberts PM; King BL; Lay JM; Lennon-Hopkins K; Sciaky D; Johnson R; Keating H; Greene N; Hernandez R; McConnell KJ; Enayetallah AE; Mattingly CJ
Database (Oxford); 2013; 2013():bat080. PubMed ID: 24288140
[TBL] [Abstract][Full Text] [Related]
8. Ranking transitive chemical-disease inferences using local network topology in the comparative toxicogenomics database.
King BL; Davis AP; Rosenstein MC; Wiegers TC; Mattingly CJ
PLoS One; 2012; 7(11):e46524. PubMed ID: 23144783
[TBL] [Abstract][Full Text] [Related]
9. Chemical-Induced Phenotypes at CTD Help Inform the Predisease State and Construct Adverse Outcome Pathways.
Davis AP; Wiegers TC; Wiegers J; Johnson RJ; Sciaky D; Grondin CJ; Mattingly CJ
Toxicol Sci; 2018 Sep; 165(1):145-156. PubMed ID: 29846728
[TBL] [Abstract][Full Text] [Related]
10. An integrative data mining approach to identifying adverse outcome pathway signatures.
Oki NO; Edwards SW
Toxicology; 2016 Mar; 350-352():49-61. PubMed ID: 27108252
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of food-relevant chemicals in the ToxCast high-throughput screening program.
Karmaus AL; Filer DL; Martin MT; Houck KA
Food Chem Toxicol; 2016 Jun; 92():188-96. PubMed ID: 27103583
[TBL] [Abstract][Full Text] [Related]
12. Understanding Conditional Associations between ToxCast
Mahmoud SY; Svensson F; Zoufir A; Módos D; Afzal AM; Bender A
Chem Res Toxicol; 2020 Jan; 33(1):137-153. PubMed ID: 31442032
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of in vivo and in vitro models of toxicity by comparison of toxicogenomics data with the literature.
Taškova K; Fontaine JF; Mrowka R; Andrade-Navarro MA
Methods; 2018 Jan; 132():57-65. PubMed ID: 28716510
[TBL] [Abstract][Full Text] [Related]
14. The Comparative Toxicogenomics Database (CTD): a resource for comparative toxicological studies.
Mattingly CJ; Rosenstein MC; Colby GT; Forrest JN; Boyer JL
J Exp Zool A Comp Exp Biol; 2006 Sep; 305(9):689-92. PubMed ID: 16902965
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships.
Liu Z; Kelly R; Fang H; Ding D; Tong W
Chem Res Toxicol; 2011 Jul; 24(7):1062-70. PubMed ID: 21627106
[TBL] [Abstract][Full Text] [Related]
16. Generating Gene Ontology-Disease Inferences to Explore Mechanisms of Human Disease at the Comparative Toxicogenomics Database.
Davis AP; Wiegers TC; King BL; Wiegers J; Grondin CJ; Sciaky D; Johnson RJ; Mattingly CJ
PLoS One; 2016; 11(5):e0155530. PubMed ID: 27171405
[TBL] [Abstract][Full Text] [Related]
17. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay.
Beames T; Moreau M; Roberts LA; Mansouri K; Haider S; Smeltz M; Nicolas CI; Doheny D; Phillips MB; Yoon M; Becker RA; McMullen PD; Andersen ME; Clewell RA; Hartman JK
Toxicol Appl Pharmacol; 2020 Jan; 387():114774. PubMed ID: 31783037
[TBL] [Abstract][Full Text] [Related]
18. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
19. Comparative Toxicogenomics Database (CTD): update 2023.
Davis AP; Wiegers TC; Johnson RJ; Sciaky D; Wiegers J; Mattingly CJ
Nucleic Acids Res; 2023 Jan; 51(D1):D1257-D1262. PubMed ID: 36169237
[TBL] [Abstract][Full Text] [Related]
20. Acute Toxicity Prediction in Multiple Species by Leveraging Mechanistic ToxCast Mitochondrial Inhibition Data and Simulation of Oral Bioavailability.
Bhhatarai B; Wilson DM; Bartels MJ; Chaudhuri S; Price PS; Carney EW
Toxicol Sci; 2015 Oct; 147(2):386-96. PubMed ID: 26139166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
